2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Paper Details

Abstracts, authors, affiliations, and disclosures.

SESSION

506. Bone Marrow Microenvironment: Poster III

Program: Poster Abstract Session
Monday, December 14, 2026
06:00 p.m. - 08:00 p.m.
MCCNO - Hall F
Technology and Procedures, Omics Technologies, Biological Processes, Genomics, Hematopoiesis, Immune Mechanism, Metabolism, Molecular Biology, Multi-Systemic Interactions, Diseases, Hemoglobinopathies, Infectious Diseases, Myeloid Malignancies, Acute Myeloid Malignancies, Chronic Myeloid Malignancies, Research, Fundamental Science, Translational Research, Study Population, Human, Adult, Animal Model
PAPER

4908 Investigating the impact of netrin-1 signaling via endothelial UNC5B on hematopoiesis and myelosuppressive recovery

Bianca Elizabeth Bean, B.S., Morgan Drew Donahoe2, Cody William Carter, BS, MS3, Pradeep Ramalingam, MD PhD4, Jason Butler, Ph.D.5
1 University of Florida, Gainesville, Florida, United States
2 University of Florida, Gainesville, Florida, United States
3 University of Florida, Gainesville, Florida, United States
4 University of Florida, Gainesville, Florida, United States
5 University of Florida, Gainesville, Florida, United States

Aging is associated with an increased risk for developing malignancies and hematopoietic deficiencies, yet geriatric patients tolerate myeloablative regimens poorly, in part due to age-related defects in hematopoietic stem cells (HSCs) and their supporting vasculature. Extensive research has demonstrated the instructive capacity of the bone marrow (BM) vasculature, specifically bone marrow endothelial cells (BMECs), on HSC function. We identified Netrin-1 (NTN1) as a BMEC-derived pro-HSC factor, whose expression declines with age. Endothelial-specific deletion of NTN1 in young mice induced premature aging phenotypes within the BM microenvironment, while supplementation of recombinant NTN1 in aged mice rejuvenated the aged BM microenvironment and restored competitive fitness and regenerative capacity of aged HSCs to youthful levels. These findings establish NTN1 as a therapeutic candidate for rejuvenating HSCs and mitigating the adverse effects of myeloablative therapy in elderly patients. However, the cell types and receptors that respond to NTN1 are undefined.

To define the mechanism underlying NTN1-induced HSC regeneration, we performed transcriptional profiling of young and aged murine BMECs and identified UNC5B as a putative NTN1 receptor whose expression increases with age. Therefore, we generated mice with endothelial-specific UNC5B knockout (UNC5BECKO) to determine its role in NTN1-mediated rejuvenation.

We first asked whether endothelial UNC5B deletion produces vascular phenotypes. Femoral BM imaging revealed significantly increased vessel diameter in UNC5BECKO mice compared to controls. To assess vascular function, we administered 150μg of 70kDa Dextran-FITC and quantified extravasation by flow cytometry and confocal imaging. UNC5BECKO mice showed significantly increased BM dextran leakage, indicating compromised vasculature integrity. Moreover, in cultured UNC5Bfl/fl BMECs, cre-GFP-mediated UNC5B knockout abolished proliferation and viability after passaging, whereas GFP-transduced controls were unaffected. Together, these data show that loss of endothelial UNC5B produces an enlarged, leaky vasculature and is essential for BMEC survival.

Given that vascular integrity is essential for HSC self-renewal and differentiation, we next examined hematopoietic phenotypes in UNC5BECKO mice. Peripheral blood and BM analyses of UNC5BECKO mice demonstrated largely normal parameters. However, UNC5BECKO mice showed a significant decrease in HSC frequency with no significant differences in BM lineage composition. To determine HSC functionality, we performed a competitive HSC transplant wherein recipients received 250 HSCs from either control or UNC5BECKO mice. The recipients which received UNC5BECKO HSCs had a significant decrease in engraftment, indicating HSC dysfunction. Moreover, we assessed recovery of the hematopoietic system following sublethal myelosuppression and found that UNC5BECKO mice were unable to recover from irradiation, exhibiting significantly lower blood counts and probability of survival when compared to control mice. Together, these findings establish that endothelial UNC5B is required for HSC function and hematopoietic regeneration.

To test whether NTN1's therapeutic effect on hematopoietic recovery is mediated by UNC5B, control and UNC5BECKO mice received a myelosuppressive dose of total body irradiation (5.5 Gy) and were injected every other day with either recombinant NTN1 or PBS, for a total of 5 injections starting one day after myelosuppression. NTN1 accelerated blood count recovery in control mice but failed to improve regeneration in UNC5BECKO mice, which instead showed significantly delayed count recovery and reduced survival. These data demonstrate that NTN1 signaling through endothelial UNC5B is required for its regenerative and pro-survival effects following myelosuppression.

Taken together, these findings demonstrate NTN1 signaling via endothelial UNC5B is critical for BM vascular integrity and hematopoietic regeneration. Clinically applying this pathway may improve recovery from myelosuppressive therapy and reduce treatment-related morbidities in aging and cancer patients undergoing myeloablative regimens.

Bianca Elizabeth Bean, B.S.: No relevant conflicts of interest to declare.